Clinical Trial Update: Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing atomoxetine to placebo for ADHD symptoms in children and adolescents with autism spectrum disorder; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder

Drugs mentioned

• Atomoxetine (Strattera) (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Autistic Disorder, Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: COMPLETED | Results posted: 2009-07-08